US EditionPublished • loading... • Updated
Janssen sues Juno over patent for schizophrenia drug Invega
Summary by Lawyerly
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Janssen sues Juno over patent for schizophrenia drug Invega
Save (0) Please login to bookmarkClose Username or Email Address Password Remember Me J&J-owned Janssen Pharmaceutica has sued Juno Pharmaceuticals, alleging the Australian off-patent drug maker is threatening to infringe its patent for a schizophrenia drug by seeking to list its own products on the PBS. Subscribe to Lawyerly to access this article.Already a subscriber? Username or Email Address Password Remember…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
